One Time. For a Lifetime.
Protection against stroke risk. Protection against oral anticoagulant (OAC) bleed risk.
The WATCHMAN FLX Implant is the one-time, minimally invasive procedure that protects your atrial fibrillation patients for life.
Over 300,000 Afib patients have left blood thinners behind with WATCHMAN LAAC Devices1
Designed to treat a broad range of patient types
Cardiologist perspectives: Freedom from OACs
A lifetime of oral anticoagulation (OAC) therapy can come with lifelong risks for NVAF patients.
Cardiologists share what it means to them to be able to tell a patient they can stop taking their blood thinner and start getting back to the joys of life without the fear of OAC bleed risk.
Learn more about WATCHMAN FLX
* Procedure success defined as successful delivery and release of a WATCHMAN FLX device into the LAA** Occurrence of one of the following events between the time of implant and within 7 days following the procedure or by hospital discharge, whichever is later: all-cause death, ischemic stroke, systemic embolism, or device or procedure related events requiring open cardiac surgery or major endovascular intervention.
- Represents all WATCHMAN models, including WATCHMAN FLX Devices.
- Kar, S., et al, Primary Outcome Evaluation of the Next Generation LAAC Device: Results from the PINNACLE FLX Trial, Circulation, 2021.